SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier

Vaccine Design for CD8 T Lymphocyte Responses

(2013) R. A. Koup et al.   Cold Spring Harbor Perspectives in Medicine

Technologies for enhanced efficacy of DNA vaccines

(2012) Fadi Saade et al.   Expert Review of Vaccines

Mutations in the GM1 Binding Site of Simian Virus 40 VP1 Alter Receptor Usage and Cell Tropism

(2012) T. G. Magaldi et al.   JOURNAL OF VIROLOGY

Circumventing Antivector Immunity by Using Adenovirus-Infected Blood Cells for Repeated Application of Adenovirus-Vectored Vaccines: Proof of Concept in Rhesus Macaques

(2012) C. Sun et al.   JOURNAL OF VIROLOGY

The mechanism of action of MF59 – An innately attractive adjuvant formulation

(2012) D.T. O’Hagan et al.   VACCINE

The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus

(2011) Tatsuya Suda et al.   ANTIVIRAL RESEARCH

Developments in virus-like particle-based vaccines for infectious diseases and cancer

(2011) Luigi Buonaguro et al.   Expert Review of Vaccines

Virus‑like particles as a vaccine delivery system: Myths and facts

(2011) Polly Roy et al.   Human vaccines & immunotherapeutics

Virus-like particle based vaccines for Alzheimer disease

(2011) Bryce Chackerian   Human vaccines & immunotherapeutics

Cancer immunotherapy using recombinantListeria monocytogenes: Transition from bench to clinic

(2011) Reshma Singh et al.   Human vaccines & immunotherapeutics

Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor

(2011) Yuichi Kitai et al.   JOURNAL OF BIOTECHNOLOGY

Learning vaccinology from viral infections

(2011) Rafi Ahmed et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A two-step ligand exchange reaction generates highly water-dispersed magnetic nanoparticles for biomedical applications

(2011) Mamoru Hatakeyama et al.   JOURNAL OF MATERIALS CHEMISTRY

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol

(2011) Roger Geiger et al.   NATURE CELL BIOLOGY

Immunological mechanisms of vaccination

(2011) Bali Pulendran et al.   NATURE IMMUNOLOGY

In vitro reconstitution of SV40 particles that are composed of VP1/2/3 capsid proteins and nucleosomal DNA and direct efficient gene transfer

(2011) Teruya Enomoto et al.   VIROLOGY

Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation

(2011) Thomas G. Magaldi et al.   VIROLOGY

Glycosaminoglycans and Sialylated Glycans Sequentially Facilitate Merkel Cell Polyomavirus Infectious Entry

(2011) Rachel M. Schowalter et al.   PLoS Pathogens

Simian virus 40 transformation, malignant mesothelioma and brain tumors

(2011) Fang Qi et al.   Expert Review of Respiratory Medicine

Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles

(2010) Sharmila Pejawar-Gaddy et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunologic Basis of Vaccine Vectors

(2010) Margaret A. Liu   IMMUNITY

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

Rationalizing the development of live attenuated virus vaccines

(2010) Adam S Lauring et al.   NATURE BIOTECHNOLOGY

Regulation of Adaptive Immunity by the Innate Immune System

(2010) A. Iwasaki et al.   SCIENCE

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

(2010) Daniel E. Speiser et al.   SEMINARS IN IMMUNOLOGY

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes

(2009) Lorena E Brown et al.   IMMUNOLOGY AND CELL BIOLOGY

Calcium Bridge Triggers Capsid Disassembly in the Cell Entry Process of Simian Virus 40

(2009) Masa-aki Kawano et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

(2009) Stephen McCartney et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Ganglioside GT1b Is a Putative Host Cell Receptor for the Merkel Cell Polyomavirus

(2009) K. D. Erickson et al.   JOURNAL OF VIROLOGY

GM1 structure determines SV40-induced membrane invagination and infection

(2009) Helge Ewers et al.   NATURE CELL BIOLOGY

HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells

(2009) B. Dai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Uncatalyzed assembly of spherical particles from SV40 VP1 pentamers and linear dsDNA incorporates both low and high cooperativity elements

(2009) Santanu Mukherjee et al.   VIROLOGY

In vivogene transfer to the CNS using recombinant SV40-derived vectors

(2008) Jean-Pierre Louboutin et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3

(2008) Takamasa Inoue et al.   JOURNAL OF BIOTECHNOLOGY

Presentation of functional foreign peptides on the surface of SV40 virus-like particles

(2008) Ryou-u Takahashi et al.   JOURNAL OF BIOTECHNOLOGY

Possible Role for Cellular Karyopherins in Regulating Polyomavirus and Papillomavirus Capsid Assembly

(2008) G. Bird et al.   JOURNAL OF VIROLOGY

Engineered lentivector targeting of dendritic cells for in vivo immunization

(2008) Lili Yang et al.   NATURE BIOTECHNOLOGY

Identification of a neutralization epitope in the VP1 capsid protein of SV40

(2008) Haruhiko Murata et al.   VIROLOGY